ACT/AA polymorphism could duplicate the APOE*ε4-associated Alzheimer's disease risk;El polimorfismo ACT/AA podría duplicar el riesgo de enfermedad de Alzheimer asociado al alelo APOE*ε4

Medicina Clinica

Volumn 123, Issue 7, 2004, Pages 251-254

  Hernández Charro, Blanca ^a   Moreno, Sira ^a   Valiente, Alberto ^a   Manubens, José María ^a   Villar, María Dolores ^b   Ramos Arroyo, María Antonia ^a  

^a Universidad Pública de Navarra   (Spain)

^b Centro de Salud del Casco Viejo   (Spain)

Author keywords

Alpha 1 antichymotrypsin (ACT); Alzheimer's disease; Apolipoprotein E; Genetic susceptibility

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

ACT GENE; AGED; ALZHEIMER DISEASE; ARTICLE; CHI SQUARE DISTRIBUTION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOSITY; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; SPAIN; STATISTICAL SIGNIFICANCE;

EID: 4844222812     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13065199     Document Type: Article

References (28)

1. Barger SW, Harmon AD. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 1997;388:878-81.
2. Dickson DW, Lee SC, Mattiace LA, Yen SH, Brosnan C. Microglia and citokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 1993;7:75-83.
3. Hull M, Strauss S, Berger M, Volk B, Bauer J. Inflammatory mechanisms in Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 1996;246:124-8.
4. McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer EG. Microglia in degenerative neurological disease. Glia 1993;7:84-92.
5. Potter H, Wefes IM, Nilsson LN. The inflammation-induced pathological chaperones ACT and APOE are necessary catalysts of Alzheimer amyloid formation. Neurobiol Aging 2001;22:923-30.
6. Abraham CR, Selkoe DJ, Potter H. Immunochemical identification of the serin proteasa inhibitor (1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 1988;52:487-501.
7. Kamboh MI, Sanghera OK, Ferrell RE, DesKosky ST. APOE*4-associated Alzheimer's disease risk is modified by α1-antichymotrypsin polymorphism. Nature Genet 1995;10:486-8.
8. Yoshiiwa A, Kamino K, Yamamoto H, Kobayashi T, Imagawa M, Nonomura Y, et al. α1-antichymotrypsin as risk a modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E ε4 allele carriers. Ann Neurol 1997;42:115-7.
9. Nacmias B, Marcon G, Tedde A, Forleo P, Latorraca S, Piacentini S, et al. Implication of α1-antichymotrypsin polymorphism in familial Alzheimer's disease. Neurosci Lett 1998;244:85-8.
10. Wang X, DeKosky ST, Luedecking-Zimmer E, Ganguli M, Kambo I. Genetic variation in alpha(1)-antichymotrypsin and its association with Alzheimer's disease. Hum Genet 2002;110:356-65.
11. Egensperger R, Kösel S, Graeber MB. Association between ACT polymorphism and Alzheimer's disease [carta]. Neurology 1998;50:575.
12. Haines JL, Pritchard ML, Saunders AM, Schildkraut JM, Growdon JH, Gaskell PC, et al. No association between alpha 1-antichymotrypsin and familial Alzheimer's disease. Ann N Y Acad Sci 1996;802:35-41.
13. Itabashi S, Araia H, Matsui T, Matsushita S, Muramatsu T, Higuchi S, et al. Absence of association of α1-antichymotrypsin polymorphisms with Alzheimer's disease: a report on autopsy-confirmed cases. Exp Neurol 1998;151:237-40.
14. Kim KW, Jhoo JH, Lee KU, Lee DY, Lee JH, Youn JY, et al. No association between alpha-1-antichymotrypsin polymorphism and Alzheimer's disease in Korean. Am J Med Genet 2000;91:355-8.
15. Müller U, Bödeker RH, Gerundt I, Kurz A. Lack of association between α1-antichymotrypsin polymorphism, Alzheimer's disease, and allele ε4 of apolipoprotein E. Neurology 1996;47:1575-7.
16. Tang G, Jiang S, Zhang M, Lin S, Qian Y, Wu X, et al. Genetic association study between α-antichymotrypsin polymorphism and Alzheimer's disease in Chinese Han population. Am J Med Genet 2000;96:133-5.
17. Ezquerra M, Blesa R, Tolosa E, Ballesta F, Oliva R. α- antichymotrypsin gene polymorphism and risk for Alzheimer's disease in the Spanish population. Neurosci Lett 1998;240:107-9.
18. Muramatsu T, Matsushita S, Arai H, Sasaki H, Higuchi S. α1-Antichymotrypsin gene polymorphism and risk for Alzheimer's disease. J Neural Transm 1996;103:1205-10.
19. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadian EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Deparment of Health and human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44.
20. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1988;16:1215.
21. Kelsey GD, Abeliovich D, McMahon CJ, Whitehouse D, Corney G, Povey S, et al. Cloning of the human alpha 1 antichymotrypsin gene and genetic analysis of the gene in relation to alpha antitrypsin deficiency. J Med Genet 1988;25:361-8.
22. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-9.
23. Álvarez V, Álvarez R, Peña J, Lahoz CH, Martínez C, Menéndez-Guisasola L, et al. Frecuencia del alelo APOE-4 en la enfermedad de Alzheimer en la población asturiana y su variación con la edad. Med Clin (Barc) 1999;113:441-3.
24. Blesa R, Adroer R, Santacruz P, Ascaso C, Tolosa E, Oliva R. High apolipoprotein E ε4 allele frequency in age-related memory decline. Ann Neurol 1996;39:548-51.
25. Combarros O, Leno C, Oterino A, Berciano J, Fernández-Luna JL, Fernández-Viadero C, et al. Gender effect on apolipoprotein E E4 allele-associated risk for sporadic Alzheimer's disease. Acta Neurol Scand 1998;97:68-71.
26. Prince JA, Feuk L, Sawyer SL, Gottfries J, Ricksten A, Nägga K, et al. Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease. Eur J Hum Genet 2001;9:437-44.
27. Lahoz C, Ordovás JM. Apo E: lípidos plasmáticos, cardiopatía isquémica y enfermedad de Alzheimer. Med Clin (Barc) 1997;109:31-6.
28. Strittmatter WJ, Weisgraber KH, Goedert M, Saunders AM, Huang D, Corder EH, et al. Hypothesis-microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Expl Neurol 1994;125:163-71.